Wall Street loses patience with Nike as turnaround drags, China weakness deepens
Nike warned that its turnaround is taking longer than it expected, leading three Wall Street banks to downgrade the stock as investors lose patience.
Eli Lilly opposes push to pass Trump’s drug pricing deals into law, CEO says
Eli Lilly opposes the White House’s push to codify “most favored nation” drug pricing into law, CEO Dave Ricks said in an interview with CNBC.
Buy these small-cap stocks set for big gains in the spring, says Oppenheimer
The small-cap Russell 2000 ended March with losses of more than 5%, but the firm has spotted a few names that could see a surge.
Franklin Templeton acquires digital assets investment firm in active crypto management push
Franklin Templeton has agreed to buy 250 Digital, which will join the newly established unit Franklin Crypto, as the firm deepens its digital assets push.
Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron & more
These are the stocks posting the largest moves in midday trading.
FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The FDA approval of Eli Lilly’s GLP-1 pill Foundayo comes nearly three months after Novo Nordisk’s oral version of Wegovy hit the market.
SpaceX confidentially files for IPO, setting stage for record offering
Elon Musk’s SpaceX is reportedly targeting a valuation of around $1.75 trillion in its forthcoming IPO.
The economy can expand so long as gas doesn’t go much above $4 a gallon, Jeremy Siegel says
‘I don’t think it’s going to get much above $4.10, unless there’s some extreme measure going on,’ the former finance professor said.
Intel shares jump 9% after buying back Ireland chip fab in sign of renewed strength
The semiconductor company will now wholly own Fab 34 after spending $14.2 billion to repurchase the 49% stake it sold to Apollo Global Management two years ago.
Wednesday, April 1, 2026: Jim Cramer discusses his next moves for the Investing Club
Post Content